One of the most promising COVID vaccine trials has been slowed due to a lack of minority participation.
CBS2's Dr. Max Gomez reports.
One of the most promising COVID vaccine trials has been slowed due to a lack of minority participation.
CBS2's Dr. Max Gomez reports.
WBZ-TV's Christina Hager reports.
In today's health headlines we talk about Moderna saying that they plan to make their COVID-19 vaccine affordable, under $40 a..